Jagsonpal Pharmaceuticals Q2 Results
- BSE: 507789
- NSE: JAGSNPHARM
- ISIN: INE048B01027
- Sector: Major Drugs
BSE
675.6
35.40 (5.53%)
35.40 (5.53%)Volume43.72 K
Updated: Mon 25 Nov, 2024 | 15:41:47
NSE
67133.30 (5.22%)
33.30 (5.22%)Volume3.97 L
Updated: Mon 25 Nov, 2024 | 15:42:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹74.69 Cr.(21.57%)
- Operating Profit₹13.94 Cr.(137.10%)
- Profit After Tax₹11.46 Cr.(115.03%)
- Operating Margin18.67%(36.48%)
Note: Comparison is on YoY basis
Quarterly - Jagsonpal Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 74.69 | 60.15 | -% | 57.83 | -% |
| Selling/ General/ Admin Expenses Total | 16.68 | 13.70 | -% | 11.70 | -% |
| Depreciation/ Amortization | 2.34 | 0.39 | -% | 0.45 | -% |
| Other Operating Expenses Total | 13.25 | 11.32 | -% | 12.67 | -% |
| Total Operating Expense | 60.75 | 51.91 | -% | 49.92 | -% |
| Operating Income | 13.94 | 8.24 | -% | 7.91 | -% |
| Net Income Before Taxes | 15.37 | 10.09 | -% | 9.96 | -% |
| Net Income | 11.46 | 7.48 | -% | 7.47 | -% |
| Diluted Normalized EPS | 4.25 | 2.85 | -% | 2.84 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST